Arimidex Prevents First Breast Cancers (CME/CE)

SAN ANTONIO (MedPage Today) -- Anastrozole (Arimidex) reduced the risk of breast cancer by 53% in high-risk postmenopausal women, a primary prevention trial showed.
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news